Figen Özçay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Figen Özçay has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Oğuz Canan
Başkent University
4 shared publications - Mehmet Haberal
Department of General Surgery, Faculty of Medicine, Baskent University, Ankara, Turkey
3 shared publications - Adnan Torgay
BAŞKENT ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications - Banu Bilezikci
Department of Pathology Güven Hospital Ankara Turkey
2 shared publications - Zeren Barış
Faculty of Medicine, Department of Pediatric Gastroenterology, Eskişehir Osmangazi University, Eskişehir, Turkey.
2 shared publications A. Sezgin
Baskent University, School of Medicine, Ankara
1 shared publication
Latest Publications
- Open Access
- 19 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 26221
Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye
This multicenter retrospective study analyzed 336 patients (236 adults, 100 children) who underwent liver transplantation (LT) for acute liver failure (ALF) between 2002 and 2019 across 14 centers in Türkiye. The aim was to evaluate pretransplant factors influencing short-term posttransplant survival. Median MELD and PELD scores were 31 and 30, respectively. The most common ALF etiologies were viral, indeterminate, and drug-induced causes. Living donor liver transplantation (LDLT) was more common in children (86.0%) than adults (57.2%). Mean posttransplant survival was 166±9 months in children and 117±6 months in adults. In adults, LDLT significantly improved survival compared to deceased donor LT (DDLT), with survival of 135 vs. 89 months (p=0.0012). Although pediatric LDLT recipients had longer mean survival than DDLT recipients (167 vs. 132 months), this difference was not statistically significant (p=0.5959). Three-month mortality was associated with low albumin and grade 4 hepatic encephalopathy (HE) in children. In adults, independent predictors of early mortality included DDLT, serum sodium >140 mEq/L, MELD >35, pH <7.3, and grade 4 HE. Our data suggest that LDLT may offer a survival advantage, particularly in adults with ALF. Identifying pretransplant risk factors is essential for improving early outcomes and guiding clinical decision-making.
- 19 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 26221
Open AccessPre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye
This multicenter retrospective study analyzed 336 patients (236 adults, 100 children) who underwent liver transplantation (LT) for acute liver failure (ALF) between 2002 and 2019 across 14 centers in Türkiye. The aim was to evaluate pretransplant factors influencing short-term posttransplant survival. Median MELD and PELD scores were 31 and 30, respectively. The most common ALF etiologies were viral, indeterminate, and drug-induced causes. Living donor liver transplantation (LDLT) was more common in children (86.0%) than adults (57.2%). Mean posttransplant survival was 166±9 months in children and 117±6 months in adults. In adults, LDLT significantly improved survival compared to deceased donor LT (DDLT), with survival of 135 vs. 89 months (p=0.0012). Although pediatric LDLT recipients had longer mean survival than DDLT recipients (167 vs. 132 months), this difference was not statistically significant (p=0.5959). Three-month mortality was associated with low albumin and grade 4 hepatic encephalopathy (HE) in children. In adults, independent predictors of early mortality included DDLT, serum sodium >140 mEq/L, MELD >35, pH <7.3, and grade 4 HE. Our data suggest that LDLT may offer a survival advantage, particularly in adults with ALF. Identifying pretransplant risk factors is essential for improving early outcomes and guiding clinical decision-making.
- Open Access
- 27 February 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
Effect of empagliflozin treatment on laboratory and clinical findings of patients with glycogen storage disease type Ib: first study from Türkiye
Objectives: Empagliflozin has been used for the treatment of over 100 glycogen storage disease type Ib (GSDIb) patients worldwide since 2019. We aimed to evaluate the effect of empagliflozin treatment on the laboratory and clinical findings of patients with GSDIb in Türkiye. Methods: Included in this multicenter study were 10 patients with GSDIb, and whose demographic, clinical and laboratory data were analyzed retrospectively. Further data for the study were garnered through a survey of patients and caregivers to evaluate the effects of empagliflozin treatment on quality of life (QoL). Results: The mean age at which the empagliflozin treatment was started was 73.2 (4–239) months. The mean duration of empagliflozin treatment was 16.9 (8–39) months. Glucosuria was identified in eight (80 %) patients undergoing empagliflozin treatment, while urogenital infections were detected in six (60 %) and hypoglycemia in two (20 %). An analysis of neutrophil levels revealed increased absolute neutrophil counts following empagliflozin treatment. Skin and/or mucosal lesions were noted in nine (90 %) patients prior to the initiation of empagliflozin treatment, but persisted in only one patient following empagliflozin treatment (10 %) (p=0.008). Empagliflozin treatment resulted in a decrease in the frequency of hospitalizations due to infection (p=0.0015). Furthermore, 80 % of the patients reported positive impact on their well-being as a result of the empagliflozin treatment, and 70 % of parents reported improvement in physical performance and activities, in the sleep quality of both the patient and parents, and in mobility. Conclusions: This study revealed empagliflozin to be effective in improving the neutrophil counts of patients with GSD Ib and in enhancing the QoL of both the patients and their caregivers.
- 27 February 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
Open AccessEffect of empagliflozin treatment on laboratory and clinical findings of patients with glycogen storage disease type Ib: first study from Türkiye
Objectives: Empagliflozin has been used for the treatment of over 100 glycogen storage disease type Ib (GSDIb) patients worldwide since 2019. We aimed to evaluate the effect of empagliflozin treatment on the laboratory and clinical findings of patients with GSDIb in Türkiye. Methods: Included in this multicenter study were 10 patients with GSDIb, and whose demographic, clinical and laboratory data were analyzed retrospectively. Further data for the study were garnered through a survey of patients and caregivers to evaluate the effects of empagliflozin treatment on quality of life (QoL). Results: The mean age at which the empagliflozin treatment was started was 73.2 (4–239) months. The mean duration of empagliflozin treatment was 16.9 (8–39) months. Glucosuria was identified in eight (80 %) patients undergoing empagliflozin treatment, while urogenital infections were detected in six (60 %) and hypoglycemia in two (20 %). An analysis of neutrophil levels revealed increased absolute neutrophil counts following empagliflozin treatment. Skin and/or mucosal lesions were noted in nine (90 %) patients prior to the initiation of empagliflozin treatment, but persisted in only one patient following empagliflozin treatment (10 %) (p=0.008). Empagliflozin treatment resulted in a decrease in the frequency of hospitalizations due to infection (p=0.0015). Furthermore, 80 % of the patients reported positive impact on their well-being as a result of the empagliflozin treatment, and 70 % of parents reported improvement in physical performance and activities, in the sleep quality of both the patient and parents, and in mobility. Conclusions: This study revealed empagliflozin to be effective in improving the neutrophil counts of patients with GSD Ib and in enhancing the QoL of both the patients and their caregivers.
- Open Access
- 30 December 2022
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 2,p. 9-12
Long-term follow-up results of pediatric liver transplants at our center
The only curative treatment for irreversible liver damage and chronic liver disease is liver transplantation (LT). Objectives: to determine long‑term follow‑up results, liver graft functions, and survival rates of pediatric LT recipients at our center. Materials and methods. All pediatric LT recipients performed between March 15, 1990 and August 11, 2022 were included in our study. Demographic characteristics, preoperative clinical features, LT indications, early and late postoperative complications, survival rates, and long‑term outcomes of pediatric LT recipients were evaluated. Results. Between March 15, 1990, and August 11, 2022, we performed 341 pediatric LTs (307 from living related donors and 34 from deceased donors). The most common indication for LT was biliary atresia. There were 3 hepatic vein, 5 portal vein, and 54 hepatic artery complications. Biliary stenosis was observed in 62 patients, and biliary leakage was observed in 54 patients. The overall five‑year survival rate was 84.1 %, and the 10‑year survival rate was 77.7 %. Conclusions. According to the long‑term outcomes of pediatric liver transplants performed in our center, liver transplantation is a successful treatment option for pediatric patients with end‑stage liver disease and irreversible liver damage. The patients’ survival rates are also satisfactory.
- 30 December 2022
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 2,p. 9-12
Open AccessLong-term follow-up results of pediatric liver transplants at our center
The only curative treatment for irreversible liver damage and chronic liver disease is liver transplantation (LT). Objectives: to determine long‑term follow‑up results, liver graft functions, and survival rates of pediatric LT recipients at our center. Materials and methods. All pediatric LT recipients performed between March 15, 1990 and August 11, 2022 were included in our study. Demographic characteristics, preoperative clinical features, LT indications, early and late postoperative complications, survival rates, and long‑term outcomes of pediatric LT recipients were evaluated. Results. Between March 15, 1990, and August 11, 2022, we performed 341 pediatric LTs (307 from living related donors and 34 from deceased donors). The most common indication for LT was biliary atresia. There were 3 hepatic vein, 5 portal vein, and 54 hepatic artery complications. Biliary stenosis was observed in 62 patients, and biliary leakage was observed in 54 patients. The overall five‑year survival rate was 84.1 %, and the 10‑year survival rate was 77.7 %. Conclusions. According to the long‑term outcomes of pediatric liver transplants performed in our center, liver transplantation is a successful treatment option for pediatric patients with end‑stage liver disease and irreversible liver damage. The patients’ survival rates are also satisfactory.
- Open Access
- 31 May 2022
- Published by Adnan Menderes University in Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
- Vol. 6 (2) , 257-269
Kronik Karaciğer Hastalığı Nedeniyle Karaciğer Nakli Yapılan Çocuklarda Malnütrisyonun Değerlendirilmesinde Antropometrik Ölçümler ve Büyüme Faktörleri
Amaç: Kronik karaciğer hastalığı, özellikle insülin benzeri büyüme faktörü-1 (IGF-1) ve insülin benzeri büyüme faktörü bağlayıcı protein-3 (IGF-BP3) başta olmak üzere büyüme faktörü proteinlerinin yapı ve işlevindeki değişikliklerle birlikte çocuklarda büyüme geriliğine neden olur. Bu çalışmanın amacı, antropometrik parametreler (AP) ve büyüme faktörü proteinlerini kullanarak karaciğer nakli (LT) yapılan kronik karaciğer hastalığı olan çocuklarında beslenme durumunu değerlendirmektir.Yöntem: Karaciğer nakli uygulanan 33 hasta ve 54 sağlıklı çocuk değerlendirildi. Hastaların AP'leri karaciğer nakli öncesi ve nakilden 1, 3, 6 ve 12 ay sonra değerlendirildi. Antropometrik parametreler, IGF-1/IGFBP-3 düzeyleri ve Child-Pugh skorları arasındaki ilişki analiz edildi.Bulgular: Kronik karaciğer hastalığı olan çocuklarda, nakil öncesi boya göre ağırlık (WFH) dışındaki tüm antropometrik ölçümler kontrol grubuna göre daha düşüktü (p<0.05). Child-Pugh skoru ile triseps deri kıvrım kalınlığı (TSF) (r=-0.387, p=0.026) ve orta-üst kol çevresi (MUAC) Z-skoru (r=-0.448, p=0.009) arasında negatif bir ilişki vardı. IGF-I ve IGFBP-3 düzeyleri, nakil öncesi hasta grubunda ortalama 35.24±14.68 ng/ml ve 1.31±0.9 µg/ml olup, kontrol grubundan daha düşüktü (69.88±67.45 ng/ml ve 3.2±1µg/ml) (sırası ile p=0.001 ve p=0.000). 12 ay sonra, hasta grubunun yaşa göre boy Z skoru (HFA) (-0.7±1.46) kontrol grubundan daha düşük (0.08±0.9) (p=0.01) iken, TSF Z skoru (0.24±0.8) ve orta kol kas alanı (MAMA) (20.67±20.28) kontrol grubundan daha yüksekti (p=0.009, p=0.004). IGF-1 ve IGFBP-3 düzeyleri nakil öncesi dönemden daha yüksekti (p=0.000). IGF-1 ve IGFBP-3 seviyeleri ile AP arasında ilişki saptanmadı.Sonuç: Kronik karaciğer hastalığı nedeniyle karaciğer nakli yapılan hastalarda malnütrisyon takibinde antropometrik parametreler IGF-1 ve IGFBP-3'e göre daha güvenilirdir.
- 31 May 2022
- Published by Adnan Menderes University in Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
- Vol. 6 (2) , 257-269
Open AccessKronik Karaciğer Hastalığı Nedeniyle Karaciğer Nakli Yapılan Çocuklarda Malnütrisyonun Değerlendirilmesinde Antropometrik Ölçümler ve Büyüme Faktörleri
Amaç: Kronik karaciğer hastalığı, özellikle insülin benzeri büyüme faktörü-1 (IGF-1) ve insülin benzeri büyüme faktörü bağlayıcı protein-3 (IGF-BP3) başta olmak üzere büyüme faktörü proteinlerinin yapı ve işlevindeki değişikliklerle birlikte çocuklarda büyüme geriliğine neden olur. Bu çalışmanın amacı, antropometrik parametreler (AP) ve büyüme faktörü proteinlerini kullanarak karaciğer nakli (LT) yapılan kronik karaciğer hastalığı olan çocuklarında beslenme durumunu değerlendirmektir.Yöntem: Karaciğer nakli uygulanan 33 hasta ve 54 sağlıklı çocuk değerlendirildi. Hastaların AP'leri karaciğer nakli öncesi ve nakilden 1, 3, 6 ve 12 ay sonra değerlendirildi. Antropometrik parametreler, IGF-1/IGFBP-3 düzeyleri ve Child-Pugh skorları arasındaki ilişki analiz edildi.Bulgular: Kronik karaciğer hastalığı olan çocuklarda, nakil öncesi boya göre ağırlık (WFH) dışındaki tüm antropometrik ölçümler kontrol grubuna göre daha düşüktü (p<0.05). Child-Pugh skoru ile triseps deri kıvrım kalınlığı (TSF) (r=-0.387, p=0.026) ve orta-üst kol çevresi (MUAC) Z-skoru (r=-0.448, p=0.009) arasında negatif bir ilişki vardı. IGF-I ve IGFBP-3 düzeyleri, nakil öncesi hasta grubunda ortalama 35.24±14.68 ng/ml ve 1.31±0.9 µg/ml olup, kontrol grubundan daha düşüktü (69.88±67.45 ng/ml ve 3.2±1µg/ml) (sırası ile p=0.001 ve p=0.000). 12 ay sonra, hasta grubunun yaşa göre boy Z skoru (HFA) (-0.7±1.46) kontrol grubundan daha düşük (0.08±0.9) (p=0.01) iken, TSF Z skoru (0.24±0.8) ve orta kol kas alanı (MAMA) (20.67±20.28) kontrol grubundan daha yüksekti (p=0.009, p=0.004). IGF-1 ve IGFBP-3 düzeyleri nakil öncesi dönemden daha yüksekti (p=0.000). IGF-1 ve IGFBP-3 seviyeleri ile AP arasında ilişki saptanmadı.Sonuç: Kronik karaciğer hastalığı nedeniyle karaciğer nakli yapılan hastalarda malnütrisyon takibinde antropometrik parametreler IGF-1 ve IGFBP-3'e göre daha güvenilirdir.
- Open Access
- 26 March 2019
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 13 (2) , 87-94
EVALUATION of THE RELATIONSHIP BETWEEN THYROID FUNCTIONS and DISEASE OUTCOME in CHILDREN WITH ACUTE LIVER FAILURE
Giriş: Çalışmamızda akut karaciğer yetmezliği ile başvuran çocuk hastalarda TSH, serbest T4 ve serbest T3 düzeylerinin hastalık seyrini belirlemedeki etkilerini inceledik.Gereç ve Yöntemler: Çalışmaya hastanemize 2000-2017 yılları arasında akut karaciğer yetmezliği ile başvuran 108 hasta içerisinden, başvuru sırasında tiroid hormonları bakılmış olan 39 hasta alındı. Bu hastaların geriye dönük olarak klinik ve laboratuvar bulguları değerlendirilerek, başvuru sırasındaki tiroid hormonları ile hastalığın seyri arasındaki ilişki incelendi.Bulgular: TSH düzeyleri hastaların 29/39’unda (%74,4) normalden düşük, serbest T3 düzeyleri 27/29 hastada (%93,1) normalden düşük saptanmıştır. Serbest T4 düzeyleri ise hastaların %69,4’sında (25/36 hasta) normal düzeylerde bulunmuştur. Hastalar, hastalığın seyrine göre, kendiliğinden düzelen hastalar (Grup 1) ile kaybedilen/nakil olan hastalar (Grup 2) olarak iki gruba ayrılmıştır. Grup 2’deki hastaların başvuru sırasında bakılan INR, total ve direk bilirubin düzeyleri ve PELD skorları grup 1’deki hastalara göre istatistiksel olarak anlamlı şekilde yüksek bulunmuştur (sırasıyla p=0,022, p<0,0001, p=0,003, p=0,004). TSH düzeylerinin ensefalopati evresi ve hemoglobin düzeyi arttıkça azaldığı (sırasıyla p=0,003, r=-0,464 ve p=0,046, r=-0,367), sT4 düzeylerinin ise serum albümin düzeyi arttıkça arttığı (p=0,005, r=0,459) saptanmıştır.Tartışma: Akut karaciğer yetmezliğinde, serum TSH ve sT3 düzeyleri baskılanmaktadır. Serum TSH düzeyleri ensefalopati evresi ve hemoglobin düzeyi arttıkça azalmakta, sT4 düzeyleri ise serum albümin düzeyi arttıkça artmaktadır.
- 26 March 2019
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 13 (2) , 87-94
Open AccessEVALUATION of THE RELATIONSHIP BETWEEN THYROID FUNCTIONS and DISEASE OUTCOME in CHILDREN WITH ACUTE LIVER FAILURE
Giriş: Çalışmamızda akut karaciğer yetmezliği ile başvuran çocuk hastalarda TSH, serbest T4 ve serbest T3 düzeylerinin hastalık seyrini belirlemedeki etkilerini inceledik.Gereç ve Yöntemler: Çalışmaya hastanemize 2000-2017 yılları arasında akut karaciğer yetmezliği ile başvuran 108 hasta içerisinden, başvuru sırasında tiroid hormonları bakılmış olan 39 hasta alındı. Bu hastaların geriye dönük olarak klinik ve laboratuvar bulguları değerlendirilerek, başvuru sırasındaki tiroid hormonları ile hastalığın seyri arasındaki ilişki incelendi.Bulgular: TSH düzeyleri hastaların 29/39’unda (%74,4) normalden düşük, serbest T3 düzeyleri 27/29 hastada (%93,1) normalden düşük saptanmıştır. Serbest T4 düzeyleri ise hastaların %69,4’sında (25/36 hasta) normal düzeylerde bulunmuştur. Hastalar, hastalığın seyrine göre, kendiliğinden düzelen hastalar (Grup 1) ile kaybedilen/nakil olan hastalar (Grup 2) olarak iki gruba ayrılmıştır. Grup 2’deki hastaların başvuru sırasında bakılan INR, total ve direk bilirubin düzeyleri ve PELD skorları grup 1’deki hastalara göre istatistiksel olarak anlamlı şekilde yüksek bulunmuştur (sırasıyla p=0,022, p<0,0001, p=0,003, p=0,004). TSH düzeylerinin ensefalopati evresi ve hemoglobin düzeyi arttıkça azaldığı (sırasıyla p=0,003, r=-0,464 ve p=0,046, r=-0,367), sT4 düzeylerinin ise serum albümin düzeyi arttıkça arttığı (p=0,005, r=0,459) saptanmıştır.Tartışma: Akut karaciğer yetmezliğinde, serum TSH ve sT3 düzeyleri baskılanmaktadır. Serum TSH düzeyleri ensefalopati evresi ve hemoglobin düzeyi arttıkça azalmakta, sT4 düzeyleri ise serum albümin düzeyi arttıkça artmaktadır.
- Open Access
- 1 July 2018
- Published by Elsevier in Gastroenterology
- Vol. 155 (1) , 130-143.e15
Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency
- 1 July 2018
- Published by Elsevier in Gastroenterology
- Vol. 155 (1) , 130-143.e15
Open AccessIntestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency
- 15 May 2018
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 29 (3) , 354-360
A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy
Background/Aims: We evaluated our 16-year single-center experience of pediatric post-transplant lymphoproliferative disorder (PTLD) cases who underwent liver transplantation between 2001 and 2017. Materials and Methods: Of the 236 pediatric patients who underwent liver transplantation between 2001 and 2017, the clinical and laboratory data of eight patients diagnosed with PTLD were reviewed. The pre-transplant Epstein-Barr virus (EBV) status of 172 patients was also recorded. Results: The total incidence of PTLD was 3.4%. The incidence of PTLD was 10% in pre-transplant EBV immunoglobulin G (IgG)-seronegative patients and 0.8% in pre-transplant EBV IgG-seropositive patients. The mean age of the patients at liver transplantation was 2.71±3.21 years, and four patients were aged below 1 year at the time of transplantation. PTLD was diagnosed at 21.81±18.1 months after transplantation. The primary site of involvement was variable among patients: peripheral and mediastinal lymph nodes, stomach and intestine, transplanted graft, bone marrow, and nasopharynx. The eosinophil count varied greatly among patients, with a mean value of 524.62±679/mm3. Three patients had a food allergy and were administered an elimination diet at the time of PTLD diagnosis. Six patients had PTLD of B-cell origin. One patient died due to neutropenic sepsis during chemotherapy, whereas seven patients were followed up in full remission for 7.75±4 years. Conclusion: PTLD is a life-threatening complication of solid-organ transplantation with a heterogeneous clinical spectrum. Food allergy had a close association with PTLD. A close follow-up of patients with risk factors and an early diagnosis with appropriate treatment may lead to a better outcome. Cite this article as: Barış Z, Özçay F, Yılmaz Özbek Ö, Haberal N, Sarıalioğlu F, Haberal M. A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy. Turk J Gastroenterol 2018; 29: 354-60.
- 15 May 2018
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 29 (3) , 354-360
A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy
Background/Aims: We evaluated our 16-year single-center experience of pediatric post-transplant lymphoproliferative disorder (PTLD) cases who underwent liver transplantation between 2001 and 2017. Materials and Methods: Of the 236 pediatric patients who underwent liver transplantation between 2001 and 2017, the clinical and laboratory data of eight patients diagnosed with PTLD were reviewed. The pre-transplant Epstein-Barr virus (EBV) status of 172 patients was also recorded. Results: The total incidence of PTLD was 3.4%. The incidence of PTLD was 10% in pre-transplant EBV immunoglobulin G (IgG)-seronegative patients and 0.8% in pre-transplant EBV IgG-seropositive patients. The mean age of the patients at liver transplantation was 2.71±3.21 years, and four patients were aged below 1 year at the time of transplantation. PTLD was diagnosed at 21.81±18.1 months after transplantation. The primary site of involvement was variable among patients: peripheral and mediastinal lymph nodes, stomach and intestine, transplanted graft, bone marrow, and nasopharynx. The eosinophil count varied greatly among patients, with a mean value of 524.62±679/mm3. Three patients had a food allergy and were administered an elimination diet at the time of PTLD diagnosis. Six patients had PTLD of B-cell origin. One patient died due to neutropenic sepsis during chemotherapy, whereas seven patients were followed up in full remission for 7.75±4 years. Conclusion: PTLD is a life-threatening complication of solid-organ transplantation with a heterogeneous clinical spectrum. Food allergy had a close association with PTLD. A close follow-up of patients with risk factors and an early diagnosis with appropriate treatment may lead to a better outcome. Cite this article as: Barış Z, Özçay F, Yılmaz Özbek Ö, Haberal N, Sarıalioğlu F, Haberal M. A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy. Turk J Gastroenterol 2018; 29: 354-60.
- 29 July 2012
- Published by Springer Nature in Pediatric Nephrology
- Vol. 27 (12) , 2269-2274
Helicobacter pylori infection and gastroduodenal lesions in children with chronic kidney disease stage V
This study aimed to investigate the dyspeptic symptoms, endoscopic findings, and frequency of Helicobacter pylori (Hp) infection in children with chronic kidney disease (CKD) stage V, and to compare findings in peritoneal dialysis (PD) and hemodialysis (HD) patients. Sixty-five patients on PD (n = 36) or HD (n = 29) were included. Age, gender, duration and type of dialysis, and dyspeptic complaints were recorded. All patients underwent endoscopy. Rapid urease tests were performed in all patients and antral biopsy examinations done in suitable patients to investigate presence of Hp infection. The mean age of patients (55 % male) was 13.9 ± 3.6 years. Frequency of dyspepsia was 43 % and was similar in HD and PD groups. The most frequent dyspeptic symptoms were early satiety (21.5 %) and bloating (17 %). Abnormal endoscopic findings were present in 81.5 % of patients (similar in both groups), and the most common lesion was gastritis (35.5 %). Hp positivity was determined in 37 % of the patients, which was similar in both groups. No significant relationship was found between dyspeptic symptoms and Hp infection. Hp infection was found to be significantly higher in 41.5 % of the patients with gastroduodenal lesions. Abnormal endoscopic findings were significantly higher in severely dyspeptic patients (88.9 %). We think performing an upper gastrointestinal tract examination and Hp screening may be helpful in renal transplant candidates with severe dyspeptic symptoms.
- 29 July 2012
- Published by Springer Nature in Pediatric Nephrology
- Vol. 27 (12) , 2269-2274
Helicobacter pylori infection and gastroduodenal lesions in children with chronic kidney disease stage V
This study aimed to investigate the dyspeptic symptoms, endoscopic findings, and frequency of Helicobacter pylori (Hp) infection in children with chronic kidney disease (CKD) stage V, and to compare findings in peritoneal dialysis (PD) and hemodialysis (HD) patients. Sixty-five patients on PD (n = 36) or HD (n = 29) were included. Age, gender, duration and type of dialysis, and dyspeptic complaints were recorded. All patients underwent endoscopy. Rapid urease tests were performed in all patients and antral biopsy examinations done in suitable patients to investigate presence of Hp infection. The mean age of patients (55 % male) was 13.9 ± 3.6 years. Frequency of dyspepsia was 43 % and was similar in HD and PD groups. The most frequent dyspeptic symptoms were early satiety (21.5 %) and bloating (17 %). Abnormal endoscopic findings were present in 81.5 % of patients (similar in both groups), and the most common lesion was gastritis (35.5 %). Hp positivity was determined in 37 % of the patients, which was similar in both groups. No significant relationship was found between dyspeptic symptoms and Hp infection. Hp infection was found to be significantly higher in 41.5 % of the patients with gastroduodenal lesions. Abnormal endoscopic findings were significantly higher in severely dyspeptic patients (88.9 %). We think performing an upper gastrointestinal tract examination and Hp screening may be helpful in renal transplant candidates with severe dyspeptic symptoms.
- Open Access
- 1 April 2011
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 52 (4) , 392-398
Value of the Likert Dyspepsia Scale in Differentiation of Functional and Organic Dyspepsia in Children
Aim: Dyspeptic symptoms may not allow clinicians to differentiate organic and functional gastrointestinal disorders. According to our dyspeptic patients' answers to dyspepsia questionnaire, we aimed to define the symptom scores directing organic dyspepsia (OD) before upper gastrointestinal endoscopy.Patients and Methods: One hundred sixty‐one patients (ages 10–17 years, mean 13.5 ± 2.3 years, male/female: 2/3) with chronic upper gastrointestinal system symptoms lasting for at least 3 months were enrolled. Patients with predominated reflux symptoms were excluded by 24‐hour pH monitoring. Before upper gastrointestinal endoscopy, severity and incidence of 8 gastrointestinal symptoms (epigastric pain, upper abdominal discomfort, retrosternal pyrosis, bitter or sour taste in mouth, halitosis, belching, nausea, and early satiety) were measured by 5‐point Likert scale. Total score indicated severity score multiplied by incidence score. Antral biopsy samples were obtained. OD is defined as peptic ulcur, erosive esophagitis, erosive or nodular gastritis, and erosive duodenitis in endoscopy and/or moderate to severe antral gastritis in histology. Functional dyspepsia (FD) is defined as normal findings/mucosal hyperemia in endoscopy and/or mild antral gastritis in antral histology. We evaluated the relation among severity and incidence scores of each dyspeptic symptom in patients with OD or FD. Age, sex, body mass index, drug history, nutritional habits, the quality of life related to dyspepsia were also investigated in patients with OD and FD.Results: According to patients' histological and endoscopic findings, 100 (62%) patients were in the OD group and 61 (38%) patients were in the FD group. Of the dyspeptic complaints, the severity, incidence, and total scores of epigastric pain were significantly correlated with dyspepsia type (respectively, P = 0.042, P = 0.028, and P = 0.005). Of 93 patients who had an epigastric pain severity of 4 and 5 (namely, moderate to severe pain), 65 (70%) patients were in the OD group and 28 (30%) patients were in the FD group. Of 68 patients who had an epigastric pain severity of 0 to 3 (no epigastric pain or mild pain), 33 (48.5%) were in the OD group and 35 (51.5%) were in the FD group, and the difference was statistically significant (P = 0.042). After analyzing the total scores of 8 dyspeptic symptoms, one by one or in different combinations, we could not find a threshold (cutoff) score value that was able to indicate OD definitely. Age, sex, body mass index, and nutritional habits were not significantly different between patients with OD or FD. Nocturnal abdominal pain, pain before meals, and resolution of symptoms after meals or ingestion of antacid drugs were not significantly related to OD. Nocturnal abdominal pain was observed to be higher in the group with moderate to severe gastric inflammation.Conclusions: In the present study, the severity, incidence, and total scores of epigastric pain were significantly related to OD; however, a cutoff value of dyspepsia symptom score for differentiation of OD and FD could not determined. In our study, Likert dyspepsia scale was not beneficial in differentiation of the OD/FD groups. We suggest that the Likert dyspepsia scale should be redesigned for children or the same scale should be applied in a larger cohort of dyspeptic children.
- 1 April 2011
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 52 (4) , 392-398
Open AccessValue of the Likert Dyspepsia Scale in Differentiation of Functional and Organic Dyspepsia in Children
Aim: Dyspeptic symptoms may not allow clinicians to differentiate organic and functional gastrointestinal disorders. According to our dyspeptic patients' answers to dyspepsia questionnaire, we aimed to define the symptom scores directing organic dyspepsia (OD) before upper gastrointestinal endoscopy.Patients and Methods: One hundred sixty‐one patients (ages 10–17 years, mean 13.5 ± 2.3 years, male/female: 2/3) with chronic upper gastrointestinal system symptoms lasting for at least 3 months were enrolled. Patients with predominated reflux symptoms were excluded by 24‐hour pH monitoring. Before upper gastrointestinal endoscopy, severity and incidence of 8 gastrointestinal symptoms (epigastric pain, upper abdominal discomfort, retrosternal pyrosis, bitter or sour taste in mouth, halitosis, belching, nausea, and early satiety) were measured by 5‐point Likert scale. Total score indicated severity score multiplied by incidence score. Antral biopsy samples were obtained. OD is defined as peptic ulcur, erosive esophagitis, erosive or nodular gastritis, and erosive duodenitis in endoscopy and/or moderate to severe antral gastritis in histology. Functional dyspepsia (FD) is defined as normal findings/mucosal hyperemia in endoscopy and/or mild antral gastritis in antral histology. We evaluated the relation among severity and incidence scores of each dyspeptic symptom in patients with OD or FD. Age, sex, body mass index, drug history, nutritional habits, the quality of life related to dyspepsia were also investigated in patients with OD and FD.Results: According to patients' histological and endoscopic findings, 100 (62%) patients were in the OD group and 61 (38%) patients were in the FD group. Of the dyspeptic complaints, the severity, incidence, and total scores of epigastric pain were significantly correlated with dyspepsia type (respectively, P = 0.042, P = 0.028, and P = 0.005). Of 93 patients who had an epigastric pain severity of 4 and 5 (namely, moderate to severe pain), 65 (70%) patients were in the OD group and 28 (30%) patients were in the FD group. Of 68 patients who had an epigastric pain severity of 0 to 3 (no epigastric pain or mild pain), 33 (48.5%) were in the OD group and 35 (51.5%) were in the FD group, and the difference was statistically significant (P = 0.042). After analyzing the total scores of 8 dyspeptic symptoms, one by one or in different combinations, we could not find a threshold (cutoff) score value that was able to indicate OD definitely. Age, sex, body mass index, and nutritional habits were not significantly different between patients with OD or FD. Nocturnal abdominal pain, pain before meals, and resolution of symptoms after meals or ingestion of antacid drugs were not significantly related to OD. Nocturnal abdominal pain was observed to be higher in the group with moderate to severe gastric inflammation.Conclusions: In the present study, the severity, incidence, and total scores of epigastric pain were significantly related to OD; however, a cutoff value of dyspepsia symptom score for differentiation of OD and FD could not determined. In our study, Likert dyspepsia scale was not beneficial in differentiation of the OD/FD groups. We suggest that the Likert dyspepsia scale should be redesigned for children or the same scale should be applied in a larger cohort of dyspeptic children.